Stocks · News reference
Clarivate has spun off its Life Sciences & Healthcare division, which has launched as a fully independent company under the new name Insira.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Cognizant reported Q3 2026 earnings of $1.49 per share, beating consensus estimates of $1.46, with revenues of $5.66 billion slightly exceeding expectations. However, the stock has declined 20.1% year-to-date compared to the S&P 500's 13.1% gain. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.
Clarivate reported that over 100 institutions across 25 countries have adopted its AI-native Web of Science Research Intelligence platform since its launch in May 2026.